Navigation Links
Quest Diagnostics Reports Second Quarter 2013 Financial Results
Date:7/18/2013

8.2$

331.3Less: Earnings allocated to participating securities

0.60.70.91.3Earnings available to Quest Diagnostics' common stockholders - basic and diluted

$

152.1$

174.5$

267.3$

330.0Weighted average common shares outstanding - basic

152.7158.5155.4158.4Effect of dilutive securities:Stock options and performance share units

1.41.31.31.3Weighted average common shares outstanding - diluted

154.1159.8156.7159.7Earnings per share attributable to Quest Diagnostics' common stockholders - basic:Income from continuing operations

$

0.99$

1.10$

1.72$

2.08Income from discontinued operations

0.080.020.210.04Net income

$

1.07$

1.12$

1.93$

2.12Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:Income from continuing operations

$

0.99$

1.09$

1.71$

2.06Income from discontinued operations

0.080.020.210.04Net income

$

1.07$

1.11$

1.92$

2.10 

2)

Adjusted amounts for operating income, operating income as a percentage of net revenues, income from continuing operations attributable to Quest Diagnostics' stockholders, and diluted earnings per common share represent the Company's results before the impact of the restructuring and integration charges and first and second quarter 2012 costs associated with the succession of our prior CEO.  Adjusted measures are presented because management believes those measures are useful adjuncts to reported results under accounting principles generally accepted in the United States when comparing results of operations from period to period.  Adjusted measures should not be considered as an alternative to the corresponding measures determined under accounting principles generally accepted in the United Sta
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
3. A 50-year quest to isolate the thermoelectric effect is now over: Magnon drag unveiled
4. Survey Reveals Paternity Questions Loom for More Than One in 10 Americans
5. S.E.D. Labs to be Acquired by Quest Diagnostics
6. Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
7. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
8. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
9. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
10. Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrigs Disease)
11. Questcor Pharmaceuticals Expands Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...   SunTrust Robinson Humphrey (STRH) today ... its equity research team in biotechnology and oilfield ... equity research demonstrates our commitment to providing our ... their investment decision making," said Biff Woodruff ... to make significant investments in differentiated content at ...
(Date:8/28/2014)... 28, 2014 A new market ... world is available from Strategic Consulting, Inc., the ... Industrial Microbiology Market Review, Fourth Edition: Global Review ... (IMMR—4) tracks and compares microbiology test volumes, market ... Europe and Asia, and forecasts future volumes and ...
(Date:8/27/2014)... Utah (PRWEB) August 27, 2014 Varian ... will expand its current Salt Lake City manufacturing facility ... outside of Utah to ultimately create 1,000 new full ... years. , “Utah is home to hardworking people ... can be credited with Varian’s success in the manufacturing ...
(Date:8/27/2014)... --  MSC , a healthcare performance improvement company advancing ... of Mary Beth Loesch to President and ... preparing companies for rapid growth and market expansion, Loesch ... Corporate Development and Healthcare. In that role, she oversaw ... as corporate strategy and marketing. Previously, Loesch served as ...
Breaking Biology Technology:SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3MSC names Mary Beth Loesch President and CEO 2
... Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it ... enrolment in its U.S. Phase II trial to,evaluate ... sarcomas that have metastasized to the lung., ... full enrolment of 52,patients, Oncolytics had to demonstrate ...
... engineers at the University of California, Berkeley, may be the ... hairs that allow the tiny lizard to scamper along vertical ... adhesive could one day be used to outfit a small ... from the millions of hairs covering a gecko,s toes, researchers ...
... PALO ALTO, Calif., Jan. 30 CV Therapeutics,Inc. (Nasdaq: ... fourth quarter and,year end financial results for 2007 after ... will webcast a conference call at,5:00 p.m. EST, 2:00 ... the live webcast, please log on to the Company,s ...
Cached Biology Technology:Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial 2Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial 3New adhesive mimics gecko toe hairs 2New adhesive mimics gecko toe hairs 3CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008 2
(Date:8/27/2014)... Calif. , Aug. 27, 2014  WaferGen Bio-systems, ... its previously announced underwritten public offering of units of ... per unit for gross proceeds of $20 million, prior ... payable by the Company.  The shares and warrants are ... Each unit sold in the offering consists of ...
(Date:8/27/2014)... step in understanding the mysteries of the human genome ... that provide the most detailed comparison yet of how ... function. , The research, appearing August 28 in ... information encoded in the three species, genomes is "read ... into chromosomes. , The results add billions of entries ...
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Law Enforcement Biometrics Market ... http://www.reportlinker.com/p02316674/Law-Enforcement-Biometrics-Market-in-North-America-2014-2018.html About Biometrics Biometrics is ... the basis of their physical or behavioral patterns. ... physiological traits such as fingerprints, face recognition, DNA, ...
Breaking Biology News(10 mins):WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Encyclopedia of how genomes function gets much bigger 2Encyclopedia of how genomes function gets much bigger 3Encyclopedia of how genomes function gets much bigger 4Law Enforcement Biometrics Market in North America 2014-2018 2Law Enforcement Biometrics Market in North America 2014-2018 3Law Enforcement Biometrics Market in North America 2014-2018 4Law Enforcement Biometrics Market in North America 2014-2018 5
... England are too hot to grow vines for making wine ... May 2008). The author, Emeritus Professor Richard Selley ... in the UK continue to rise as predicted, the Thames ... contain many vineyards, will be too hot to support wine ...
... the largest baby boom ever documented for the stock, with ... With typical annual averages of 50 to 100 million new ... puzzled by the huge increase and its ramifications for stock ... found one - healthy adults. In a study to ...
... have a unique ability to eat toxic mulberry leaves ... closer to understanding why: silkworms contain a special digestive ... Mulberry leaves contain an extremely high amount of ... and thus are potentially quite toxic. However, one type ...
Cached Biology News:Research suggests parts of UK could be too hot for wine making by 2080 2Healthy parents provide clues to survival of young haddock on Georges Bank 2
...
Request Info...
... pPIC9K and pPIC3.5K vectors carry the kanamycin ... Reagent in Pichia. Spontaneous generation of multiple ... to increased levels of Geneticin Reagent. Pichia ... screened for their level of resistance to ...
... Immunogen: Synthetic peptide derived from the ... bovine Math-2. Specificity: Specific for ... Rat (positive controls: human U251 A172 ... and rat brain homogenates)Storage: Store at ...
Biology Products: